Literature DB >> 10939846

Carbapenem-resistant Pseudomonas aeruginosa with acquired bla(vim) metallo-beta-lactamase determinants, Italy.

G M Rossolini, M L Riccio, G Cornaglia, L Pagani, C Lagatolla, L Selan, R Fontana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10939846      PMCID： PMC2640878          DOI： 10.3201/eid0603.000314

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  16 in total

1.  Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors:  T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa.

Authors:  Roberta Migliavacca; Jean-Denis Docquier; Claudia Mugnaioli; Gianfranco Amicosante; Rossana Daturi; Kyungwon Lee; Gian Maria Rossolini; Laura Pagani
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals.

Authors:  F Luzzaro; E F Viganò; D Fossati; A Grossi; A Sala; C Sturla; M Saudelli; A Toniolo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 3.267

5.  First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.

Authors:  T Conceição; A Brízio; A Duarte; R Barros
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals.

Authors:  Maria Letizia Riccio; Lucia Pallecchi; Jean-Denis Docquier; Stefania Cresti; Maria Rosaria Catania; Laura Pagani; Cristina Lagatolla; Giuseppe Cornaglia; Roberta Fontana; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

8.  First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.

Authors:  Gian Maria Rossolini; Francesco Luzzaro; Roberta Migliavacca; Claudia Mugnaioli; Beatrice Pini; Filomena De Luca; Mariagrazia Perilli; Simona Pollini; Melissa Spalla; Gianfranco Amicosante; Antonio Toniolo; Laura Pagani
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

9.  Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase.

Authors:  Gianluigi Lombardi; Francesco Luzzaro; Jean-Denis Docquier; Maria Letizia Riccio; Mariagrazia Perilli; Alessandra Colì; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Toniolo
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

10.  Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.

Authors:  Cristina Lagatolla; Elisabetta Edalucci; Lucilla Dolzani; Maria Letizia Riccio; Filomena De Luca; Erica Medessi; Gian Maria Rossolini; Enrico Angelo Tonin
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.